Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Merck KGaA makes membrane moves in Ireland
by Craig Bettenhausen
May 26, 2022
| A version of this story appeared in
Volume 100, Issue 19
Merck KGaA will spend roughly $470 million to expand its capacity for life sciences membranes and other filtration technology in Cork, Ireland. The firm says the move, which will create over 370 jobs, is the largest single-site investment to date for its life sciences business. The new capacity will serve customers making drugs, vaccines, gene therapies, and diagnostics. “Ireland is central to our strategy to drive long-term growth,” life sciences CEO Matthias Heinzel says in a statement.
Chemical & Engineering News
ISSN 0009-2347
Copyright © 2024 American Chemical Society
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter